CA Stock MarketDetailed Quotes

BCT BriaCell Therapeutics Corp

Watchlist
  • 0.780
  • -0.050-6.02%
15min DelayMarket Closed Dec 23 16:00 ET
34.48MMarket Cap-0.63P/E (TTM)

About BriaCell Therapeutics Corp Company

BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.

Company Profile

SymbolBCT
Company NameBriaCell Therapeutics Corp
Founded2006
MarketTSE
Employees18
Fiscal Year Ends07-31
Address235-15th Street Suite 300, 3rd Floor, Bellevue Centre
CityVancouver
CountryCAN
Zip CodeV7T 2X1
Phone+1 888 485-6340

Company Executives

  • Name
  • Position
  • Salary
  • Dr. William V. Willia F.R.C.P.,M.D.
  • President, Chief Executive Officer and Director
  • 1.08M
  • Gadi Levin, C.A.,M.B.A.
  • Chief Financial Officer, Principal Accounting Officer and Corporate Secretary
  • 520.73K
  • Dr. Miguel A. Lopez-Lago, PhD
  • Chief Scientific Officer
  • 393.61K
  • Dr. Giuseppe Del Priore, M.D.,M.P.H.
  • Chief Medical Officer
  • 780.85K
  • Jamieson Bondarenko, C.F.A.
  • Chairman of the Board
  • 664.11K
  • Richard J. Berman
  • Director
  • --
  • Dr. Vaughn C. Embro-Pantalony, M.B.A.
  • Independent Director
  • 175.88K
  • Dr. Jane A. Gross, PhD
  • Independent Director
  • 146.86K
  • Martin E. Schmieg, C.P.A.
  • Independent Director
  • 166.86K
  • Dr. Rebecca A. Taub,M.D.
  • Independent Director
  • 141.87K
Trending CA Stocks
Dividend Kings of Canada Dividend Kings of Canada

Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.